NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

NWBO hired two consultants that began stage 1 reimbursement preparation, sometime around August 2024 ( August is imo), according to the last 10q. I personally would be disappointed if this has not started with a cancer drug fund referral which, I personally believe can be started before evidence submission to NICE. I think, and this is just me, that interim funding could be used to finance around 30 to 45 million for commercial therapy and parallel Eden testing, in order to gather enough data to then proceed with NICE reimbursement. That’s just my hypothesis, but to me it would account for the timing you and others keep scratching your heads about.

Let me add that, at this time juncture, I don’t think, JMHO, the actual NICE submission will occur until around the end of October. Why? Because that’s ten years from when the last patient was randomized and began treatment on DCVax-l. I don’t agree with waiting that long, but the scientific community (including Big Pharma) is/are drawn to round numbers.